IAI Versus Sham as Prophylaxis Against Conversion to Neovascular AMD

NCT02462889 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

128

Enrollment

OTHER

Sponsor class

Conditions

Age-Related Macular Degeneration

Interventions

DRUG: Intravitreal aflibercept injection
DRUG: Placebo

Sponsor

Jeffrey S Heier

Collaborators

[object Object]